Trending...
- DivX Unveils Revamped Resource Guide to Help Users Easily Convert MKV to MP4
- AI Transforming the POD Industry: Innovations and Opportunities
- 'The Tech Neck Epidemic: How Screen Time Is Negatively Impacting Our Spine,' Says Auburn Chiropractor Dr. Gordon Fimreite
AVENTURA, Fla. - WisconsinEagle -- Dr. Jeff Gelblum, Neurologist at First Choice Neurology, has brought together clinical, imaging, and laboratory capabilities to provide rapid diagnosis and treatment to individuals suffering from Alzheimer's disease.
The patient journey of Alzheimer's evaluation and management involves a clinical assessment to determine the level of cognitive impairment, and imaging studies of the brain, MRI, and PET scans to identify the presence of brain amyloid plaques. Also included are laboratory capabilities to inform the tolerability of the new anti-Alzheimer medication, and an experienced infusion team capable of providing the new class of FDA-approved medication in a comfortable setting.
Dr. Gelblum's highly integrated program will eliminate the long delays and fragmented care that typically plague patients seeking Alzheimer's treatment.
He observes, "that the new class of disease-modifying treatments are only approved in mild Alzheimer's which offers only a short window of opportunity to treat. In the US and abroad, it can often take up to a year to get a neurology appointment, and by that point, the patient may have progressed to a point where they might no longer respond to treatment."
More on Wisconsin Eagle
Dr. Gelblum's program eliminates the delay and provides a quick and comprehensive work-up in the Aventura medical district, just north of Miami, Florida.
Dr. Gelblum boasts that "within 48 hours we can diagnose and begin infusion therapy. This means that the patient can check in to our on-campus hotel on a Tuesday evening, undergo evaluation in our clinic Wednesday morning, receive diagnostic testing Wednesday and Thursday, and then obtain their infusion treatment on Friday."
For those patients who reside out of town, his infusion center can dispense medication to-go for follow-up infusion treatments in their hometown medical facility. This is ideal for out-of-town patients who may not have easy access to a neurologist. He can then follow the patient remotely via telehealth.
His Aventura clinic is easily accessible via Miami or Fort Lauderdale international airports.
Dr. Gelblum has a global patient population who has discovered the ease of access and convenience of care provided by this program. He has patients from the UK, Spain, France, Israel, Russia, South Korea, Central and South America, and the Caribbean. They are diagnosed in his Aventura clinic and then followed up remotely via Skype, WhatsApp, FaceTime, or any manner of live audiovisual interface.
More on Wisconsin Eagle
Dr. Gelblum observes, "that in this day and age of disease-modifying therapy and instantaneous telecommunications, it is unacceptable for medically necessary neurological care and treatment to be delayed."
He looks forward to welcoming Alzheimer patients from all over to his Aventura, Florida clinic.
About Jeffrey Gelblum, MD, FAAN
Dr. Jeff Gelblum is a neurologist with First Choice Neurology located in Aventura, Florida. He is considered a global thought leader in the neurologic treatment of Alzheimer's, dementia, seizure disorders, Parkinson's, diabetic and peripheral nerve disorder, Familial Amyloid Polyneuropathy, Covid Long-Hauler, trauma, and chronic pain, and has hosted educational symposia in the U.S. and overseas. To learn more about Dr. Gelblum, visit https://www.fcneurology.net/business-directory/788/jeffrey-gelblum-md/
The patient journey of Alzheimer's evaluation and management involves a clinical assessment to determine the level of cognitive impairment, and imaging studies of the brain, MRI, and PET scans to identify the presence of brain amyloid plaques. Also included are laboratory capabilities to inform the tolerability of the new anti-Alzheimer medication, and an experienced infusion team capable of providing the new class of FDA-approved medication in a comfortable setting.
Dr. Gelblum's highly integrated program will eliminate the long delays and fragmented care that typically plague patients seeking Alzheimer's treatment.
He observes, "that the new class of disease-modifying treatments are only approved in mild Alzheimer's which offers only a short window of opportunity to treat. In the US and abroad, it can often take up to a year to get a neurology appointment, and by that point, the patient may have progressed to a point where they might no longer respond to treatment."
More on Wisconsin Eagle
- "When The Call Hits Home" Podcast Dives Into First Responder Financial Wellness with Brian Box
- Artbound: "The Cheech" Awarded Two 2025 LA Area EMMY Awards — Honored in ARTS & MUSIC COMPOSITION
- Rising Conservative Star Jordan Brace Emerges as Influential Political Voice with Elite Washington Connections
- Conservative Latinos for PA Shaping the Future of Hispanic Community, Guest State Treasurer Stacy Garrity
- Colbert Packaging Announces Startup Moxie Program for Students
Dr. Gelblum's program eliminates the delay and provides a quick and comprehensive work-up in the Aventura medical district, just north of Miami, Florida.
Dr. Gelblum boasts that "within 48 hours we can diagnose and begin infusion therapy. This means that the patient can check in to our on-campus hotel on a Tuesday evening, undergo evaluation in our clinic Wednesday morning, receive diagnostic testing Wednesday and Thursday, and then obtain their infusion treatment on Friday."
For those patients who reside out of town, his infusion center can dispense medication to-go for follow-up infusion treatments in their hometown medical facility. This is ideal for out-of-town patients who may not have easy access to a neurologist. He can then follow the patient remotely via telehealth.
His Aventura clinic is easily accessible via Miami or Fort Lauderdale international airports.
Dr. Gelblum has a global patient population who has discovered the ease of access and convenience of care provided by this program. He has patients from the UK, Spain, France, Israel, Russia, South Korea, Central and South America, and the Caribbean. They are diagnosed in his Aventura clinic and then followed up remotely via Skype, WhatsApp, FaceTime, or any manner of live audiovisual interface.
More on Wisconsin Eagle
- Chasing Creative Plants Roots in Palm Coast, Builds Marketing Systems for Modern B2B Brands
- David M. White, DDS Celebrates 500 Five-Star Reviews in Reno
- BJ Simmons Releases Trapped In
- Shincheonji Reaches World-Class Level At International Taekwondo Competition
- TNT Removal & Disposal Celebrates Record Year Helping Pennsylvania Property Owners Reclaim Space
Dr. Gelblum observes, "that in this day and age of disease-modifying therapy and instantaneous telecommunications, it is unacceptable for medically necessary neurological care and treatment to be delayed."
He looks forward to welcoming Alzheimer patients from all over to his Aventura, Florida clinic.
About Jeffrey Gelblum, MD, FAAN
Dr. Jeff Gelblum is a neurologist with First Choice Neurology located in Aventura, Florida. He is considered a global thought leader in the neurologic treatment of Alzheimer's, dementia, seizure disorders, Parkinson's, diabetic and peripheral nerve disorder, Familial Amyloid Polyneuropathy, Covid Long-Hauler, trauma, and chronic pain, and has hosted educational symposia in the U.S. and overseas. To learn more about Dr. Gelblum, visit https://www.fcneurology.net/business-directory/788/jeffrey-gelblum-md/
Source: First Choice Neurology
0 Comments
Latest on Wisconsin Eagle
- Philadelphia HVAC Company Bypasses Paid Search Ads, Citing Cost Savings for Customers
- Block AI Labs Empowers Startups with Affordable, AI-Driven Software Development from U.S. and Colombia Ask ChatGPT
- "The U.S. is Running Out of Workers" – New Book Offers Urgent, Research-Backed Solution to the Workforce Crisis
- LandGate® Releases Q2 2025 U.S. Data Center Development Summary
- Macon's Historic Douglass Theatre Names Toni Simmons Henson as Artistic Director for Inaugural Series Celebrating the Spirit of American Theatre
- Natural Field Celebrates 20th Anniversary, Advancing Functional Ingredients Globally
- Anern Shines at SOLAR AFRICA 2025 with Integrated Solar + Storage Solutions
- 'The Tech Neck Epidemic: How Screen Time Is Negatively Impacting Our Spine,' Says Auburn Chiropractor Dr. Gordon Fimreite
- DivX Unveils Revamped Resource Guide to Help Users Easily Convert MKV to MP4
- Max Life Agency taking part in PHP Takeoff event in Las Vegas Featuring Coach K and Ray Lewis
- AI Transforming the POD Industry: Innovations and Opportunities
- Sexual Harassment Law Firm CA Offers Free Consultations to Empower Harassment Victims in California
- $10 Million Controlling Interest Acquisition Completed for Concerts.com & TicketStub.com by Emerging Sports, Entertainment & Gaming AI Powered Company
- PebblePad Announces Strategic Partnership with UERU to Advance Undergraduate Education Across U.S. Research Universities
- Editorial Freelancers Association to Host Virtual Conference and Celebrate 55 Years of Editorial Excellence
- New Slotozilla Tool Helps Americans Find the Most Affordable Cities to Live Based on Their Income
- CCHR: Regulators Warn ADHD Drug May Trigger Homicidal Thoughts, Parents Not Informed
- Divorce Made Simpler: Interview with Yamil Francisco, Founder of Divorce in Florida Online
- A New Era of Fashion Collaboration Begins: Introducing the Global Fashion Membership Platform
- Josh & Heidi get Real, Raw, Authentic; Heidi's 18 Year Bipolar Misdiagnosis, Josh's Arrest, Heidi's Deadly Disease in Rehab, Relapses, Volatility